Top 10 Analyst Upgrades and Downgrades: Cubist, Marvell, PG and More

Print Email

Investors and traders are usually on the lookout for new research ideas that will generate higher income or more profits. 24/7 Wall St. reviews many analyst research calls from Wall Street and from boutique firms to find great ideas in value stocks, growth stocks and dividend stocks. Some are stocks to buy, while some ideas are even stocks to sell. These are 10 of the top analyst upgrades, downgrades and initiations seen from select Wall Street research calls this Friday ahead of a three-day weekend.

Aixtron SE (NASDAQ: AIXG) was cut to Neutral from Buy at Goldman Sachs.

Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) was started as Buy at Deutsche Bank.

Cubist Pharmaceuticals Inc. (NASDAQ: CBST) was cut to Neutral from Buy at Janney.

Marvell Technology Group Ltd. (NASDAQ: MRVL) was cut to Underperform from Market Perform at JMP Securities.

Melco Crown Entertainment Ltd. (NASDAQ: MPEL) was cut to Neutral from Outperform at Macquarie.

Nordson Corp. (NASDAQ: NDSN) cut to Perform from Outperform at Oppenheimer and cut to Market Perform from Outperform at BMO Capital Markets.

Pandora Media Inc. (NYSE: P) was raised to Outperform from Sector Perform at RBC Capital.

Procter & Gamble Co. (NYSE: PG) raised to Buy from Neutral on new CEO news at UBS.

Salesforce.com Inc. (NYSE: CRM) was cut to Neutral from Outperform after earnings at Wedbush; shares are down more than 7%. Also, Oppenheimer defends the stock and says to buy on weakness.

The Wendy’s Company (NASDAQ: WEN) was raised to Buy from Neutral at Janney.

The analyst team at Goldman Sachs is now calling for higher interest rates as early as this fall.

Value investors now have many choices to choose from in the oil, gas and energy sectors.

RSS Facebook Twitter